Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Base excision repair in nuclear and mitochondrial DNA.
Dianov GL, Souza-Pinto N, Nyaga SG, Thybo T, Stevnsner T, Bohr VA. Dianov GL, et al. Among authors: thybo t. Prog Nucleic Acid Res Mol Biol. 2001;68:285-97. doi: 10.1016/s0079-6603(01)68107-8. Prog Nucleic Acid Res Mol Biol. 2001. PMID: 11554304 Review.
Phenotypic Responses to a Lifestyle Intervention Do Not Account for Inter-Individual Variability in Glucose Tolerance for Individuals at High Risk of Type 2 Diabetes.
O'Donoghue G, Kennedy A, Andersen GS, Carr B, Cleary S, Durkan E, Davis H, Færch K, Fitzpatrick P, Kenny H, McCaffrey N, Monedero J, Murphy E, Noone J, Suvitaival T, Thybo T, Wheeler M, Vistisen D, Nolan JJ, O'Gorman DJ. O'Donoghue G, et al. Among authors: thybo t. Front Physiol. 2019 Mar 26;10:317. doi: 10.3389/fphys.2019.00317. eCollection 2019. Front Physiol. 2019. PMID: 30971951 Free PMC article.
An evaluation of the DEXLIFE 'self-selected' lifestyle intervention aimed at improving insulin sensitivity in people at risk of developing type 2 diabetes: study protocol for a randomised controlled trial.
O'Donoghue GM, Kennedy A, Andersen GS, Durkan E, Thybo T, Sinnott M, Nolan JJ, O'Gorman DJ. O'Donoghue GM, et al. Among authors: thybo t. Trials. 2015 Nov 18;16:529. doi: 10.1186/s13063-015-1042-1. Trials. 2015. PMID: 26581687 Free PMC article. Clinical Trial.
The DEXLIFE study methods: identifying novel candidate biomarkers that predict progression to type 2 diabetes in high risk individuals.
Andersen GS, Thybo T, Cederberg H, Orešič M, Esteller M, Zorzano A, Carr B, Walker M, Cobb J, Clissmann C, O'Gorman DJ, Nolan JJ; DEXLIFE Consortium. Andersen GS, et al. Among authors: thybo t. Diabetes Res Clin Pract. 2014 Nov;106(2):383-9. doi: 10.1016/j.diabres.2014.07.025. Epub 2014 Jul 27. Diabetes Res Clin Pract. 2014. PMID: 25125339 Clinical Trial.
Yeast artificial chromosomes employed for random assembly of biosynthetic pathways and production of diverse compounds in Saccharomyces cerevisiae.
Naesby M, Nielsen SV, Nielsen CA, Green T, Tange TO, Simón E, Knechtle P, Hansson A, Schwab MS, Titiz O, Folly C, Archila RE, Maver M, van Sint Fiet S, Boussemghoune T, Janes M, Kumar AS, Sonkar SP, Mitra PP, Benjamin VA, Korrapati N, Suman I, Hansen EH, Thybo T, Goldsmith N, Sorensen AS. Naesby M, et al. Among authors: thybo t. Microb Cell Fact. 2009 Aug 13;8:45. doi: 10.1186/1475-2859-8-45. Microb Cell Fact. 2009. PMID: 19678954 Free PMC article.